These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23619251)

  • 21. Gut microbiota and probiotics in chronic liver diseases.
    Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
    Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of probiotics in treatment of nonalcoholic fatty liver disease].
    Chen M; Wang MC; Ni R; Wang J; Wang L; Wang GN; Zhang LY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):77-80. PubMed ID: 28297790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric non alcoholic fatty liver disease: more on novel treatment targets.
    Vajro P; Paolella G; Poeta M; Pizza C; Sangermano M; Massa G
    BMC Pediatr; 2013 Jul; 13():109. PubMed ID: 23870449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.
    Compare D; Coccoli P; Rocco A; Nardone OM; De Maria S; Cartenì M; Nardone G
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):471-6. PubMed ID: 22546554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.
    Iacono A; Raso GM; Canani RB; Calignano A; Meli R
    J Nutr Biochem; 2011 Aug; 22(8):699-711. PubMed ID: 21292470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
    Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
    World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.
    Nicoletti A; Ponziani FR; Biolato M; Valenza V; Marrone G; Sganga G; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Sep; 25(33):4814-4834. PubMed ID: 31543676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbiota and the Liver: A Tale of 2 Cities: A Narrative View in 2 Acts.
    Koch M
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S183-S187. PubMed ID: 27741171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics.
    Meng X; Li S; Li Y; Gan RY; Li HB
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30297615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.
    Malaguarnera G; Giordano M; Nunnari G; Bertino G; Malaguarnera M
    World J Gastroenterol; 2014 Nov; 20(44):16639-48. PubMed ID: 25469033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity, fatty liver disease and intestinal microbiota.
    Arslan N
    World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis.
    Scarpellini E; Lupo M; Iegri C; Gasbarrini A; De Santis A; Tack J
    Rev Recent Clin Trials; 2014; 9(3):141-7. PubMed ID: 25514911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis.
    Qamar AA
    J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota.
    Han R; Ma J; Li H
    Front Med; 2018 Dec; 12(6):645-657. PubMed ID: 30178233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric NAFLD: the Future role of Patient-Tailored Probiotics Therapy.
    Putignani L; Alisi A; Nobili V
    J Pediatr Gastroenterol Nutr; 2016 Jul; 63 Suppl 1():S6-8. PubMed ID: 27380600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
    Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
    Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota changes and chronic hepatitis C virus infection.
    Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota.
    Doulberis M; Kotronis G; Gialamprinou D; Kountouras J; Katsinelos P
    Metabolism; 2017 Jun; 71():182-197. PubMed ID: 28521872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota.
    Cui Y; Wang Q; Chang R; Zhou X; Xu C
    J Agric Food Chem; 2019 Mar; 67(10):2754-2762. PubMed ID: 30798598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.